List of Tables
Table 1. Global Rare Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hematology
Table 3. Key Players of Oncology
Table 4. Global Rare Disease Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Rare Disease Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Rare Disease Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Rare Disease Diagnostics Market Share by Region (2020-2025)
Table 8. Global Rare Disease Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Rare Disease Diagnostics Market Share by Region (2026-2031)
Table 10. Rare Disease Diagnostics Market Trends
Table 11. Rare Disease Diagnostics Market Drivers
Table 12. Rare Disease Diagnostics Market Challenges
Table 13. Rare Disease Diagnostics Market Restraints
Table 14. Global Rare Disease Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Rare Disease Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Rare Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Diagnostics as of 2024)
Table 17. Ranking of Global Top Rare Disease Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Rare Disease Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Rare Disease Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Rare Disease Diagnostics, Product and Application
Table 21. Global Key Players of Rare Disease Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Disease Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Rare Disease Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Rare Disease Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Rare Disease Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Rare Disease Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Rare Disease Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Rare Disease Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Rare Disease Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Rare Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Rare Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Rare Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Rare Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Rare Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Rare Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Rare Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Rare Disease Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Rare Disease Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Rare Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Rare Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Rare Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Rare Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Rare Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Rare Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Retrophin Company Details
Table 47. Retrophin Business Overview
Table 48. Retrophin Rare Disease Diagnostics Product
Table 49. Retrophin Revenue in Rare Disease Diagnostics Business (2020-2025) & (US$ Million)
Table 50. Retrophin Recent Development
Table 51. 3billion Company Details
Table 52. 3billion Business Overview
Table 53. 3billion Rare Disease Diagnostics Product
Table 54. 3billion Revenue in Rare Disease Diagnostics Business (2020-2025) & (US$ Million)
Table 55. 3billion Recent Development
Table 56. 23andMe Company Details
Table 57. 23andMe Business Overview
Table 58. 23andMe Rare Disease Diagnostics Product
Table 59. 23andMe Revenue in Rare Disease Diagnostics Business (2020-2025) & (US$ Million)
Table 60. 23andMe Recent Development
Table 61. QIAGEN Company Details
Table 62. QIAGEN Business Overview
Table 63. QIAGEN Rare Disease Diagnostics Product
Table 64. QIAGEN Revenue in Rare Disease Diagnostics Business (2020-2025) & (US$ Million)
Table 65. QIAGEN Recent Development
Table 66. Illumina Company Details
Table 67. Illumina Business Overview
Table 68. Illumina Rare Disease Diagnostics Product
Table 69. Illumina Revenue in Rare Disease Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Illumina Recent Development
Table 71. PerkinElmer Company Details
Table 72. PerkinElmer Business Overview
Table 73. PerkinElmer Rare Disease Diagnostics Product
Table 74. PerkinElmer Revenue in Rare Disease Diagnostics Business (2020-2025) & (US$ Million)
Table 75. PerkinElmer Recent Development
Table 76. Strand Life Sciences Company Details
Table 77. Strand Life Sciences Business Overview
Table 78. Strand Life Sciences Rare Disease Diagnostics Product
Table 79. Strand Life Sciences Revenue in Rare Disease Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Strand Life Sciences Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report
List of Figures
Figure 1. Rare Disease Diagnostics Picture
Figure 2. Global Rare Disease Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rare Disease Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Hematology Features
Figure 5. Oncology Features
Figure 6. Global Rare Disease Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Rare Disease Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospital Laboratories Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Genetic Testing Laboratories Case Studies
Figure 11. Cancer Research Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Rare Disease Diagnostics Report Years Considered
Figure 14. Global Rare Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Rare Disease Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Rare Disease Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Rare Disease Diagnostics Market Share by Players in 2024
Figure 18. Global Top Rare Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Rare Disease Diagnostics Revenue in 2024
Figure 20. North America Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Rare Disease Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Rare Disease Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Rare Disease Diagnostics Market Share by Region (2020-2031)
Figure 34. China Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Rare Disease Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Rare Disease Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Rare Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Retrophin Revenue Growth Rate in Rare Disease Diagnostics Business (2020-2025)
Figure 50. 3billion Revenue Growth Rate in Rare Disease Diagnostics Business (2020-2025)
Figure 51. 23andMe Revenue Growth Rate in Rare Disease Diagnostics Business (2020-2025)
Figure 52. QIAGEN Revenue Growth Rate in Rare Disease Diagnostics Business (2020-2025)
Figure 53. Illumina Revenue Growth Rate in Rare Disease Diagnostics Business (2020-2025)
Figure 54. PerkinElmer Revenue Growth Rate in Rare Disease Diagnostics Business (2020-2025)
Figure 55. Strand Life Sciences Revenue Growth Rate in Rare Disease Diagnostics Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
